{
    "code": "02023363",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023363",
    "time": "2021-12-10 03:23:13",
    "許可證字號": "衛署藥輸字第023363號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/01\/21",
    "發證\/登錄日期": "91\/01\/21",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202336304",
    "中文品名": "斥消靈錠1毫克",
    "英文品名": "RAPAMUNE TABLETS 1MG",
    "適應症": "與CYCLOSPORINE及皮質類固醇合併使用來預防病人腎臟移殖後之器官排斥。",
    "劑型": "119糖衣錠",
    "包裝": "4-1000錠盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "SIROLIMUS, SIROLIMUS NANOSYSTEMS DISPERSION",
    "限制項目": "02輸　入",
    "申請商名稱": "0929101100  美商惠氏藥廠（亞洲）股份有限公司台灣分公司",
    "申請商地址": "台北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "": "IRELAND",
            "製程": "bulk"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司(委託包裝)",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "FDE0247000  PFIZER MANUFACTURING DEUTSCHLAND GMBH",
            "製造廠廠址": "BETRIEBSSTATTE FREIBURG, MOOSWALDALLEE 1, 79090 FREIBURG, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "分包裝廠"
        }
    ],
    "CCC號列": "30049091001 抗排斥醫藥製劑Immunosuppressive preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200039620",
            "成分名稱": "SIROLIMUS NANOSYSTEMS DISPERSION",
            "含量描述": "(150MG\/G)",
            "含量": "1.5000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9200039600",
            "成分名稱": "SIROLIMUS",
            "含量描述": "100%",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "無",
        "形狀": "三角形",
        "標記一": "RAPAMUNE 1 MG",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Rapamune Tablets 1 mg 錠劑外觀-104-09-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023363&Seq=437&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "中文印妥仿單A4_Rapamune Tablets 0.5 mg 1 mg 2 mg LLD USPI 201908-4-110-11-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023363&Seq=008&Type=9"
        },
        {
            "title": "202011 Rapa 1mg_CTN and Foil-109-12-03(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023363&Seq=003&Type=8"
        },
        {
            "title": "Rapamune Tablets 1 mg carton and foil-104-09-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023363&Seq=002&Type=8"
        }
    ]
}